Mikołaj Szczęsny

Mr. Mikołaj Szczęsny

orcid

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 May 2026 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
PCPatryk Cegiełka
Patryk Cegiełka
APAdrian Pal
Adrian Pal
KCKrzysztof Cienkowski
Krzysztof Cienkowski
MKMałgorzata Katra
Małgorzata Katra
MSMikołaj Szczęsny
Mikołaj Szczęsny
MSMaria Sicińska
Maria Sicińska
Burnout, defined in the ICD-11 classification as a response to chronic stress, is characterized by feelings of exhaustion, mental distancing from work, and a reduced sense of professional efficacy. This paper summarizes previous publications regarding the scale of this phenomenon, its symptoms, and coping strategies among medical students in Poland, compared with international data. The review indicates that the problem is global and increasing in magnitude— in Poland, up to 53% of students may exhibit symptoms of exhaustion, and 42% struggle with burnout, with higher rates observed among women and senior students. The article discusses the symptomatology of the syndrome, including somatic symptoms such as headaches and fatigue, as well as psychological manifestations, including cynicism, depersonalization, and impostor syndrome. Coping strategies are also presented, contrasting destructive methods (substance use, social isolation) with effective preventive techniques such as mindfulness training, cognitive reinterpretation of mistakes, and peer support.

9 June 2026 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
PDF file
AAAleksandra Adamczyk
Aleksandra Adamczyk
KŻKarolina Żeżawska
Karolina Żeżawska
APAdrian Pal
Adrian Pal
PCPatryk Cegiełka
Patryk Cegiełka
MSMaria Magdalena Sicińska
Maria Magdalena Sicińska
MKMałgorzata Katra
Małgorzata Katra
Background Multiple myeloma is a malignant hematological neoplasm characterized by the uncontrolled proliferation of monoclonal plasma cells in the bone marrow and monoclonal protein synthesis, resulting in numerous organ complications. Despite significant therapeutic advances early diagnosis still remains a critical factor in treatment efficacy. Diagnostic delays in multiple myeloma are among the longest of all hematological malignancies, often leading to irreversible organ damage. This issue is most prevalent in primary care, where low oncological vigilance and difficulties in interpreting early non-specific clinical manifestations often result in multiple consultations before a specialist referral. Aim The aim of this study is to analyze the factors contributing to diagnostic delays of multiple myeloma in general practice, evaluate the most common non-specific symptoms, and emphasize the importance of timely diagnosis. Material and Methods A narrative review was conducted using databases such as PubMed and Polish medical journals. The study analyzed publications concerning multiple myeloma patients, with a particular focus on the frequency of specific symptoms and the underlying causes of delayed diagnosis. Conclusions The average time to diagnose multiple myeloma is one of the longest in oncology. A key barrier is the non-specific clinical presentation, which leads to symptoms being attributed to more common chronic conditions. Consequently, nearly half of all patients require at least three primary care visits before receiving a preliminary diagnosis. Because diagnosis within three months correlates directly with longer remission, rapid intervention is vital. Improving the diagnostic process by routinely incorporating CRAB criteria and increasing oncological vigilance among primary care physicians are priority challenges to improve patient prognosis.

Verified
Journal Article
Open access
PDF file
AKAnna Kozub
Anna Kozub
RSRafał Szarek
Rafał Szarek
MSMikołaj Szczęsny
Mikołaj Szczęsny
Dagmara JaworskaDagmara Jaworska
Dagmara Jaworska
WMWojciech Młynarski
Wojciech Młynarski
ŁSŁukasz Sędek
Łukasz Sędek
The research on cytokine or growth factor (GF) release by leukaemic blasts is a largely unexplored area. This study aimed to evaluate the differential secretory potential of paediatric B-cell precursor and T-cell acute lymphoblastic leukaemia (BCP-ALL and T-ALL, respectively) and acute myeloid leukaemia cells (AMLs) for selected GFs, both basally and upon stimulation with phytohemagglutinin (PHA), lipopolysaccharide (LPS), or phorbol 12-myristate 13-acetate with ionophore A23187 (PMA + I). The concentrations of five GFs: granulocyte colony-stimulating factor (G-CSF), granulocyte-macrophage colony-stimulating factor (GM-CSF), basic fibroblast growth factor (b-FGF), vascular endothelial growth factor (VEGF), and platelet-derived growth factor (PDGF) in the supernatants were measured using the Bio-Plex multiplex immunoassay. AML blasts showed the highest basal concentrations of G-CSF, GM-CSF, and VEGF. PHA and LPS stimulation non-selectively enhanced the secretion of G-CSF, GM-CSF, VEGF, and PDGF in BCP-ALL and AML blasts. PMA + I was the strongest GF release inducer, particularly for BCP-ALL and T-ALL blasts, with the latter also showing higher responsiveness to PHA and LPS. Our findings reveal differential, leukaemia-type dependent GF secretion patterns. Lineage-specific responses may be exploitable for targeted therapeutic approaches for distinct AL types. This study is the first to comprehensively assess the extracellular secretion of multiple GFs by paediatric AL cells in cultures using a Bio-Plex multiplex immunoassay.

12 September 2026 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
PDF file
MSMaria Sicińska
Maria Sicińska
MKMałgorzata Katra
Małgorzata Katra
MSMikołaj Szczęsny
Mikołaj Szczęsny
APAdrian Pal
Adrian Pal
KCKrzysztof Cienkowski
Krzysztof Cienkowski
AAAleksandra Adamczyk
Aleksandra Adamczyk
Pancreatic cancer is one of the most aggressive malignancies and a leading cause of cancer-related mortality worldwide. Prognosis remains poor due to late diagnosis, as early-stage disease is usually asymptomatic or presents with non-specific symptoms, and the lack of effective screening results in most patients being diagnosed at an advanced stage. This review evaluates challenges in pancreatic cancer diagnosis, summarizes available diagnostic methods, and highlights the role of primary care physicians in early detection. Evidence published between 2015 and 2026 was analyzed. A structured literature search was conducted using PubMed and Google Scholar. Search terms included "pancreatic cancer", "early diagnosis", "screening", "biomarkers", "imaging", "liquid biopsy", "circulating tumor DNA", and "artificial intelligence". Original studies, reviews, and clinical guidelines were included. CT remains the primary imaging modality, though sensitivity decreases for small lesions. Endoscopic ultrasound improves detection and enables tissue sampling. CA 19-9 has limited early diagnostic value. Liquid biopsy methods show promise but remain under validation. Radiomics and AI may enhance detection of subtle imaging features. Primary care physicians are essential for recognizing suspicious symptoms and ensuring timely referral. Early diagnosis remains challenging due to non-specific symptoms, limited screening, and diagnostic shortcomings. A multimodal approach combining imaging, biomarkers, and emerging technologies is needed. Greater awareness among primary care physicians and continued development of liquid biopsy and AI tools may improve outcomes.

21 April 2026 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
PDF file
IGIzabella Głowacka
Izabella Głowacka
MŚMarcin Ślot
Marcin Ślot
MKMałgorzata Katra
Małgorzata Katra
APAdrian Pal
Adrian Pal
PCPatryk Cegiełka
Patryk Cegiełka
MSMaria Sicińska
Maria Sicińska
Depression represents a significant global public health problem, negatively affecting patients’ quality of life and social functioning. Despite the increasing availability of effective pharmacological and psychotherapeutic interventions, a substantial proportion of patients fail to achieve full symptom remission. [1] Recently, growing attention has been directed toward physical activity as a non-pharmacological approach supporting the treatment of depression. Multiple studies indicate that regular exercise may lead to a reduction in depressive symptoms and improvements in cognitive function. In addition, other non-pharmacological interventions, including probiotics [2], meditation, light therapy [3,4], and physical training, have been investigated for their potential antidepressant effects. One of the proposed mechanisms underlying the beneficial effects of physical activity, apart from its anti-inflammatory properties and stimulation of endorphin release, is the modulation of brain-derived neurotrophic factor (BDNF) expression. BDNF plays a crucial role in neuroplasticity, neurogenesis, and the regulation of synaptic function, particularly within the hippocampus, as well as in the spinal cord and peripheral nervous system. [5,6] The aim of this narrative review is to summarize and critically discuss current evidence on the effects of physical activity on BDNF levels and its role in antidepressant mechanisms, highlighting its potential clinical relevance in the management of depressive disorders.

14 July 2026 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
ACAlicja Cienkowska
Alicja Cienkowska
AAAleksandra Adamczyk
Aleksandra Adamczyk
KŻKarolina Żeżawska
Karolina Żeżawska
MŚMarcin Ślot
Marcin Ślot
APAdrian Pal
Adrian Pal
IGIzabella Głowacka
Izabella Głowacka
Background: Congenital heart disease (CHD) is one of the most common congenital conditions. Advances in treatment have improved survival, shifting focus toward long-term outcomes such as quality of life (QoL/HRQoL). Appropriately prescribed physical activity is generally safe, though its effects may vary by age and CHD subtype.Aim: This scoping review aimed to map evidence on physical activity and exercise-based interventions and their association with QoL in children, adolescents, and adults with CHD.Materials and Methods: The review followed PRISMA-ScR guidelines. English-language studies published between 2010 and 2025 were identified through PubMed and Google Scholar. Eligible studies included original research (e.g., randomized controlled trials, cohort, and cross-sectional studies) assessing physical activity or exercise interventions and reporting QoL/HRQoL and/or cardiorespiratory fitness outcomes.Results: In children, early individualized programs are safe and may improve exercise tolerance and motor outcomes. In adolescents, digital and behavioral interventions targeting increases in moderate-to-vigorous physical activity (MVPA) show mixed results, with greater benefits in those with low baseline activity. Structured aerobic training improves cardiopulmonary exercise testing (CPET) outcomes but often does not increase daily activity. In adults, most studies report improved cardiopulmonary fitness (VO₂peak), while effects on biomarkers and QoL vary. Respiratory training may improve selected patient-reported outcomes but has less consistent effects on VO₂peak. Serious adverse events are rare.Conclusions: Exercise in patients with CHD is safe and improves fitness; however, its effects on QoL/HRQoL are heterogeneous and depend on age, context, and CHD subtype. A key gap is the mismatch between improved fitness and daily activity, highlighting the need for long-term, multicomponent programs with objective monitoring and standardized HRQoL measures.